Dr Lal PathLabs reports 16.4% profit rise in Q2 FY26
pre-market1 source ↓written by the desknot a recommendation
- in Q2 FY26
- ₹152 crore
- with revenue
- ₹731 crore
- year-on-year
- 10.7%
- Board approved
- ₹7 interim dividend
- for shareholders
- 1:1 bonus issue
Dr Lal PathLabs reported profit after tax rising 16.4% to ₹152 crore in Q2 FY26, with revenue at ₹731 crore, up 10.7% year-on-year. The Board approved a ₹7 interim dividend and a 1:1 bonus issue for shareholders. This positive performance may enhance investor sentiment in the healthcare sector.
• EBITDA margin steady at 30.7%
• Earnings-per-share increased to ₹18.1
• Revenue growth signals strong demand
Not investment advice. For informational purposes only.